Drug Pipeline News

>

Latest News

Lawrence Eichenfield, MD, Rocco Serrao, MD, react to roflumilast approval for pediatric atopic dermatitis | Image credit: Contemporary Pediatrics
Lawrence Eichenfield, MD; and Rocco Serrao, MD, react to roflumilast approval for pediatric atopic dermatitis

October 7th 2025

A pair of roflumilast clinical trial investigators react to the FDA approval of the 0.05% formulation to treat atopic dermatitis in children 2 to 5 years.

FDA approves roflumilast cream 0.05% for atopic dermatitis for children 2 to 5 years | Image credit: Contemporary Pediatrics
FDA approves roflumilast cream 0.05% for atopic dermatitis for children aged 2 to 5 years

October 6th 2025

September's FDA Focus: Approvals and pipeline updates in pediatrics | Image credit: Contemporary Pediatrics
September's FDA Focus: Approvals and pipeline updates in pediatrics

October 3rd 2025

FDA news in pediatrics: September 2025 | Image credit: Contemporary Pediatrics
FDA news in pediatrics: September 2025

October 1st 2025

5 pediatric FDA decisions to watch for in Q4 2025 | Image credit: Contemporary Pediatrics
Key pediatric FDA decisions to watch for in Q4 2025

September 30th 2025

Latest CME Events & Activities
<1
...
1314151617
© 2025 MJH Life Sciences

All rights reserved.